As an attempt to assess of MC activity in the plasma could be used as a marker of AAA progression, we measured plasma levels of tryptase at the end of the procedure (Day 28 of AngII infusion); however, tryptase was undetectable in any mouse. Here, AGT is linked to triple-A syndrome.